| Breast cancer liver metastasis: current and future treatment approaches NS Rashid, JM Grible, CV Clevenger, JC Harrell Clinical & experimental metastasis 38, 263-277, 2021 | 56 | 2021 |
| The human intermediate prolactin receptor is a mammary proto-oncogene JM Grible, P Zot, AL Olex, SE Hedrick, JC Harrell, AE Woock, MO Idowu, ... NPJ Breast Cancer 7 (1), 37, 2021 | 22 | 2021 |
| Identification of nuclear export inhibitor-based combination therapies in preclinical models of triple-negative breast cancer NS Rashid, NS Hairr, G Murray, AL Olex, TJ Leftwich, JM Grible, J Reed, ... Translational Oncology 14 (12), 101235, 2021 | 9 | 2021 |
| Discovering synergistic compounds with BYL-719 in PI3K overactivated basal-like PDXs DC Boyd, EK Zboril, AL Olex, TJ Leftwich, NS Hairr, HA Byers, ... Cancers 15 (5), 1582, 2023 | 6 | 2023 |
| Serine residues 726 and 780 have nonredundant roles regulating STAT5a activity in luminal breast cancer AE Woock, JM Grible, AL Olex, JC Harrell, P Zot, M Idowu, CV Clevenger Scientific reports 11 (1), 13506, 2021 | 6 | 2021 |
| Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograft MG Dozmorov, MA Marshall, NS Rashid, JM Grible, A Valentine, AL Olex, ... Scientific Reports 13 (1), 5420, 2023 | 2 | 2023 |
| Evaluation of the NRF1-proteasome axis as a therapeutic target in breast cancer HA Byers, AN Brooks, JR Vangala, JM Grible, A Feygin, CV Clevenger, ... Scientific Reports 13 (1), 15843, 2023 | 1 | 2023 |
| Publisher Correction: Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograft MG Dozmorov, MA Marshall, NS Rashid, JM Grible, A Valentine, AL Olex, ... Scientific Reports 13 (1), 7522, 2023 | 1 | 2023 |
| Transcriptomic changes underlying EGFR inhibitor resistance in human and mouse models of basal-like breast cancer NS Rashid, DC Boyd, AL Olex, JM Grible, AK Duong, MA Alzubi, ... Scientific Reports 12 (1), 21248, 2022 | 1 | 2022 |
| Stratification of Tamoxifen Synergistic Combinations for the Treatment of ER+ Breast Cancer EK Zboril, JM Grible, DC Boyd, NS Hairr, TJ Leftwich, MF Esquivel, ... Cancers 15 (12), 3179, 2023 | | 2023 |
| Abstract P1-13-23: Carboplatin resistance-associated changes in the 3D chromatin landscape of a triple-negative breast cancer Patient-Derived Xenograft M Dozmorov, M Marshall, N Rashid, J Grible, AD Valentine, A Olex, ... Cancer Research 83 (5_Supplement), P1-13-23-P1-13-23, 2023 | | 2023 |
| Abstract P3-09-06: Targeting tumor subpopulations based on single-cell transcriptomics JM Grible, T Leftwich, AL Olex, AK Duong, N Hairr, NS Rashid, TM Smith, ... Cancer Research 82 (4_Supplement), P3-09-06-P3-09-06, 2022 | | 2022 |
| SAT-139 STAT5A Regulation by Serine Phosphorylation in Breast Cancer AE Woock, JM Grible, P Zot, JC Harrell, I Michael, CV Clevenger Journal of the Endocrine Society 4 (Supplement_1), SAT-139, 2020 | | 2020 |
| SAT-130 The Intermediate Prolactin Receptor Is a Breast Cancer Oncogene JM Grible, P Zot, JC Harrell, M Idowu, CV Clevenger Journal of the Endocrine Society 4 (Supplement_1), SAT-130, 2020 | | 2020 |
| Abstract P4-08-02: The human intermediate prolactin receptor is a breast cancer oncogene JM Grible, SE Hedrick, CV Clevenger Cancer Research 80 (4_Supplement), P4-08-02-P4-08-02, 2020 | | 2020 |
| The human intermediate prolactin receptor: a breast cancer proto-oncogene JM Grible | | 2020 |
| The role of the intermediate prolactin receptor in breast cancer oncogenesis JM Grible, CV Clevenger Cancer Research 79 (13_Supplement), 870-870, 2019 | | 2019 |
